One such technology is MelaFind, a device that facilitates the early detection of melanoma. Utilizing varying wavelengths of light, the noninvasive, handheld instrument painlessly examines the skin for abnormalities that may indicate cancerous cells. MelaFind inspects 2.5 millimeters below the surface of the skin, allowing dermatologists to analyze patients’ moles for irregular growth patterns. Because the device both records and stores diagnostic data, physicians can track changes in a mole over time.
MelaFind requires only seconds of contact with the skin to obtain data. Afterwards, it analyzes the results and provides a detailed report within minutes. Dermatologists can then use MelaFind’s diagnostic information to determine whether or not a biopsy may be necessary, taking into account additional factors, such as a patient’s history of moles and sunburns, his or her skin type, and any family history of melanoma.